Acerta Pharma
AcquiredA Member of the AstraZeneca Group
- Website
- acerta-pharma.com
- Acquisition Date
- Dec 2015
About
Acerta Pharma is AstraZeneca's European research and development centre in the Netherlands, focused on discovering and developing novel therapies. The organization applies covalent-binding technology to create highly selective medicines and develops treatments from chemistry through clinical evidence. Its work concentrates on hematology and hematologic conditions, including the development of acalabrutinib, a selective Bruton's tyrosine kinase inhibitor.
Summary
Acerta Pharma is a Biotech company. Investors include AstraZeneca.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Dec 2015
Investors
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/acerta-pharma"><img src="https://indexed.vc/api/badge/company/acerta-pharma" alt="Acerta Pharma on Indexed.vc" width="260" height="76" /></a>